mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.008 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.009 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.01 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |